Principles and clinical methods of body surface gastric mapping: Technical review.

Gregory O'Grady, Chris Varghese, Gabriel Schamberg, Stefan Calder, Peng Du, William Xu, Jan Tack, Charlotte Daker, Hayat Mousa, Thomas L Abell, Henry P Parkman, Vincent Ho, L Alan Bradshaw, Anthony Hobson, Christopher N Andrews, Armen A Gharibans

Journal: Neurogastroenterology and motility 2023;35(10):e14556

PMID: 36989183

Abstract

Chronic gastric symptoms are common, however differentiating specific contributing mechanisms in individual patients remains challenging. Abnormal gastric motility is present in a significant subgroup, but reliable methods for assessing gastric motor function in clinical practice are lacking. Body surface gastric mapping (BSGM) is a new diagnostic aid, employs multi-electrode arrays to measure and map gastric myoelectrical activity non-invasively in high resolution. Clinical adoption of BSGM is currently expanding following studies demonstrating the ability to achieve specific patient subgrouping, and subsequent regulatory clearances. An international working group was formed in order to standardize clinical BSGM methods, encompassing a technical group developing BSGM methods and a clinical advisory group. The working group performed a technical literature review and synthesis focusing on the rationale, principles, methods, and clinical applications of BSGM, with secondary review by the clinical group. The principles and validation of BSGM were evaluated, including key advances achieved over legacy electrogastrography (EGG). Methods for BSGM were reviewed, including device design considerations, patient preparation, test conduct, and data processing steps. Recent advances in BSGM test metrics and reference intervals are discussed, including four novel metrics, being the 'principal gastric frequency', BMI-adjusted amplitude, Gastric Alimetry Rhythm Index™, and fed: fasted amplitude ratio. An additional essential element of BSGM has been the introduction of validated digital tools for standardized symptom profiling, performed simultaneously during testing. Specific phenotypes identifiable by BSGM and the associated symptom profiles were codified with reference to pathophysiology. Finally, knowledge gaps and priority areas for future BSGM research were also identified by the working group.

© 2023 The Authors. Neurogastroenterology & Motility published by John Wiley & Sons Ltd.

Address: Department of Surgery, The University of Auckland, Auckland, New Zealand.; Alimetry Ltd, Auckland, New Zealand.; Auckland Bioengineering Institute, The University of Auckland, Auckland, New Zealand.; Department of Surgery, The University of Auckland, Auckland, New Zealand.; Department of Surgery, The University of Auckland, Auckland, New Zealand.; Alimetry Ltd, Auckland, New Zealand.; Alimetry Ltd, Auckland, New Zealand.; Alimetry Ltd, Auckland, New Zealand.; Auckland Bioengineering Institute, The University of Auckland, Auckland, New Zealand.; Department of Gastroenterology, University Hospitals, Leuven, Belgium.; Division of Gastroenterology, Lustgarten Motility Center, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Division of Gastroenterology, Hepatology and Nutrition, University of Louisville, Louisville, Kentucky, USA.; Department of Medicine, Temple University Hospital, Philadelphia, Pennsylvania, USA.; Western Sydney University, Sydney, New South Wales, Australia.; Vanderbilt University, Nashville, Tennessee, USA.; Functional Gut Clinic, London, UK.; Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.